---
title: Blog | Michael Artinger, PhD
description: Michael Artinger, PhD, Executive Vice President and Managing Director VIC Colorado Branch, has spent his career transforming innovation into commercial opportunity. He has worked closely with universities and inventors across the nation to recognize the potential of their discoveries and has deep domain expertise across multiple verticals, including therapeutics, vaccines, medical devices, diagnostics and information technology/software. Dr. Artinger earned his Doctorate degree in Biology focusing on Developmental and Cell Biology, as well as his Baccalaureate degree in Applied Ecology from the University of California at Irvine.
---
[](https://victech.com)
- [Innovators](https://victech.com/innovators/)
- [Inventors](https://victech.com/inventors/)
- [Foundry](https://victech.com/foundry/)
- [Fellows](https://victech.com/fellows/)
- [Investors](https://victech.com/investors-2/)
- [About Us](https://victech.com/about/)
- [Business Model](https://victech.com/business-model/)
- [Portfolio Companies](https://victech.com/portfolio-companies/)
- [Careers](https://victech.com/careers/)
- [Team](https://victech.com/team/)
- [News](https://blog.victech.com/)
- [Journal](https://victech.com/journal/)
- [Contact](https://victech.com/contact/)
- [Subscribe](https://victech.com/newsletter/)
[](https://victech.com)
- [Innovators](https://victech.com/innovators/)
- [Inventors](https://victech.com/inventors/)
- [Foundry](https://victech.com/foundry/)
- [Fellows](https://victech.com/fellows/)
- [Investors](https://victech.com/investors-2/)
- [About Us](https://victech.com/about/)
- [Business Model](https://victech.com/business-model/)
- [Portfolio Companies](https://victech.com/portfolio-companies/)
- [Careers](https://victech.com/careers/)
- [Team](https://victech.com/team/)
- [News](https://blog.victech.com/)
- [Journal](https://victech.com/journal/)
- [Contact](https://victech.com/contact/)
- [Subscribe](https://victech.com/newsletter/)
- [Innovators](https://victech.com/innovators/)
- [Inventors](https://victech.com/inventors/)
- [Foundry](https://victech.com/foundry/)
- [Fellows](https://victech.com/fellows/)
- [Investors](https://victech.com/investors-2/)
- [About](https://victech.com/about/)
- [Our Team](https://victech.com/team/)
- [Business Model](https://victech.com/business-model/)
- [Portfolio Companies](https://victech.com/portfolio-companies/)
- [Careers](https://victech.com/careers/)
- [News](https://blog.victech.com/)
- [Contact](https://victech.com/contact/)
# Recent News and Events
## Michael Artinger, PhD
Michael Artinger, PhD, Executive Vice President and Managing Director VIC Colorado Branch, has spent his career transforming innovation into commercial opportunity. He has worked closely with universities and inventors across the nation to recognize the potential of their discoveries and has deep domain expertise across multiple verticals, including therapeutics, vaccines, medical devices, diagnostics and information technology/software. Dr. Artinger earned his Doctorate degree in Biology focusing on Developmental and Cell Biology, as well as his Baccalaureate degree in Applied Ecology from the University of California at Irvine.
Find me on:
### Recent Posts
[](https://blog.victech.com/fostering-life-science-innovation-part-4-it-takes-a-village-federal-state-local-other-support)
## [Fostering Life Science Innovation: Part 4: It Takes a Village? (Federal, State, Local & Other Support)](https://blog.victech.com/fostering-life-science-innovation-part-4-it-takes-a-village-federal-state-local-other-support)
Posted by [Michael Artinger, PhD](https://blog.victech.com/author/michael-artinger-phd) [June 15, 2026](https://blog.victech.com/archive/2026/)
Over the previous three articles in this series, we've looked at the life science innovation ecosystem from different angles: the macro view of how it's structured \[An Ecosystem Roadmap\], the role of patient need in...
[Read More](https://blog.victech.com/fostering-life-science-innovation-part-4-it-takes-a-village-federal-state-local-other-support)
[](https://blog.victech.com/fostering-life-science-innovation-part-3-moving-university-inventions-forward)
## [Fostering Life Science Innovation: Part 3 – Moving University Inventions Forward](https://blog.victech.com/fostering-life-science-innovation-part-3-moving-university-inventions-forward)
Posted by [Michael Artinger, PhD](https://blog.victech.com/author/michael-artinger-phd) [November 19, 2025](https://blog.victech.com/archive/2026/)
In the third part of the continuing series on the broader topic of Fostering Life Science Innovation, we zoom in on the important concept of transitioning technologies from the university lab to the next stage of...
[Read More](https://blog.victech.com/fostering-life-science-innovation-part-3-moving-university-inventions-forward)
[](https://blog.victech.com/fostering-life-science-innovation-part-2-inventing-with-the-end-in-mind)
## [Fostering Life Science Innovation: Part 2 – Inventing with the End in Mind](https://blog.victech.com/fostering-life-science-innovation-part-2-inventing-with-the-end-in-mind)
Posted by [Michael Artinger, PhD](https://blog.victech.com/author/michael-artinger-phd) [May 16, 2025](https://blog.victech.com/archive/2026/)
The first article in this series \[blog.victech.com/fostering-life-science-innovation-part-1-an-ecosystem-roadmap\] set the stage by defining the primary components, drivers and benefits of life science innovation...
[Read More](https://blog.victech.com/fostering-life-science-innovation-part-2-inventing-with-the-end-in-mind)
[](https://blog.victech.com/fostering-life-science-innovation-part-1-an-ecosystem-roadmap)
## [Fostering Life Science Innovation: Part 1 – An Ecosystem Roadmap](https://blog.victech.com/fostering-life-science-innovation-part-1-an-ecosystem-roadmap)
Posted by [Michael Artinger, PhD](https://blog.victech.com/author/michael-artinger-phd) [February 13, 2025](https://blog.victech.com/archive/2026/)
Introduction What does it take to create and nurture life science innovation and why is it important? No doubt, this is a broad and deep topic, and would not be adequately addressed in a single white paper. As a result,...
[Read More](https://blog.victech.com/fostering-life-science-innovation-part-1-an-ecosystem-roadmap)
[](https://blog.victech.com/maximizing-synergies-between-venture-studios-and-life-science-companies)
## [Maximizing Synergies Between Venture Studios and Life Science Companies](https://blog.victech.com/maximizing-synergies-between-venture-studios-and-life-science-companies)
Posted by [Michael Artinger, PhD](https://blog.victech.com/author/michael-artinger-phd) [September 17, 2024](https://blog.victech.com/archive/2026/)
As has been thoroughly discussed by this author and others, the so-called “valley of death” is a critical barrier for the advancement of life science (therapeutic, vaccine, medical device, diagnostic and related)...
[Read More](https://blog.victech.com/maximizing-synergies-between-venture-studios-and-life-science-companies)
[](https://blog.victech.com/neurexis-therapeutics-secures-3-million-nih-grant-to-advance-neuroprotective-treatment-for-global-cerebral-ischemia)
## [Neurexis Therapeutics Secures $3 Million NIH Grant to Advance Neuroprotective Treatment for Global Cerebral Ischemia](https://blog.victech.com/neurexis-therapeutics-secures-3-million-nih-grant-to-advance-neuroprotective-treatment-for-global-cerebral-ischemia)
Posted by [Michael Artinger, PhD](https://blog.victech.com/author/michael-artinger-phd) [September 16, 2024](https://blog.victech.com/archive/2026/)
Aurora, CO - Neurexis Therapeutics, a leading biopharmaceutical company focused on developing neuroprotective interventions, has been awarded a prestigious $3 million Phase II Small Business Innovation Research (SBIR)...
[Read More](https://blog.victech.com/neurexis-therapeutics-secures-3-million-nih-grant-to-advance-neuroprotective-treatment-for-global-cerebral-ischemia)
[](https://blog.victech.com/challenges-and-solutions-for-university-technology-commercialization-part-3-gap-programs)
## [Part 3: Challenges and Solutions for University Technology Commercialization – Gap Programs](https://blog.victech.com/challenges-and-solutions-for-university-technology-commercialization-part-3-gap-programs)
Posted by [Michael Artinger, PhD](https://blog.victech.com/author/michael-artinger-phd) [January 04, 2024](https://blog.victech.com/archive/2026/)
Both universities and regional entities have become more active in providing critically needed support to faculty innovators with commercially relevant technologies.
[Read More](https://blog.victech.com/challenges-and-solutions-for-university-technology-commercialization-part-3-gap-programs)
[](https://blog.victech.com/solaris-vaccines-awarded-funding-from-nih-to-develop-novel-influenza-vaccine-using-solavax-platform)
## [Solaris Vaccines Awarded Funding from NIH to Develop Novel Influenza Vaccine using SolaVAX™ Platform](https://blog.victech.com/solaris-vaccines-awarded-funding-from-nih-to-develop-novel-influenza-vaccine-using-solavax-platform)
Posted by [Michael Artinger, PhD](https://blog.victech.com/author/michael-artinger-phd) [June 20, 2023](https://blog.victech.com/archive/2026/)
This NIAID SBIR will evaluate an innovative approach for producing superior vaccines more quickly and cost-effectively. FORT COLLINS, CO – Solaris Vaccines, Inc. announced today that it has received a Small Business...
[Read More](https://blog.victech.com/solaris-vaccines-awarded-funding-from-nih-to-develop-novel-influenza-vaccine-using-solavax-platform)
[](https://blog.victech.com/neurexis-therapeutics-awarded-direct-to-phase-ii-sbir-grant-from-nih)
## [Direct-to-Phase II SBIR Grant from NIH Awarded to Neurexis Therapeutics to Evaluate Neuroprotective Therapeutic in Stroke Preclinical Assessment Network (SPAN)](https://blog.victech.com/neurexis-therapeutics-awarded-direct-to-phase-ii-sbir-grant-from-nih)
Posted by [Michael Artinger, PhD](https://blog.victech.com/author/michael-artinger-phd) [April 18, 2023](https://blog.victech.com/archive/2026/)
A promising approach for preventing cognitive and behavioral impairment following ischemia Aurora, CO - Neurexis Therapeutics, Incorporated, announces it has been awarded $900,000 in funding from a Direct-to-Phase II...
[Read More](https://blog.victech.com/neurexis-therapeutics-awarded-direct-to-phase-ii-sbir-grant-from-nih)
[](https://blog.victech.com/solaris-vaccines-adds-izabela-ragan-as-director-of-researc-and-development)
## [Solaris Vaccines Adds Izabela Ragan as Director of Research and Development for the SolaVAX™ Platform](https://blog.victech.com/solaris-vaccines-adds-izabela-ragan-as-director-of-researc-and-development)
Posted by [Michael Artinger, PhD](https://blog.victech.com/author/michael-artinger-phd) [April 18, 2023](https://blog.victech.com/archive/2026/)
FORT COLLINS, CO – Solaris Vaccines, Inc. announced today that Dr. Izabela Ragan (DVM, PhD), an expert in novel vaccine technologies, has joined as Director of Research and Development. The Company is developing a...
[Read More](https://blog.victech.com/solaris-vaccines-adds-izabela-ragan-as-director-of-researc-and-development)
[All posts](https://blog.victech.com/all) [Next](https://blog.victech.com/author/michael-artinger-phd/page/2)
FEATURED RESOURCES
[](https://blog.victech.com/vic-tech-announces-new-class-of-fellows-2025)
##### [Updates](https://blog.victech.com/vic-tech-announces-new-class-of-fellows-2025)
VIC Tech Announces New Class of Fellows
[](https://blog.victech.com/women-shaping-life-sciences-laura-lyons)
##### [Insight](https://blog.victech.com/women-shaping-life-sciences-laura-lyons)
Women Shaping Life Sciences: Laura Lyons on Purpose, Perseverance, and Patient-Centered Innovation
[](https://blog.victech.com/fostering-life-science-innovation-part-4-it-takes-a-village-federal-state-local-other-support)
##### [White Paper](https://blog.victech.com/fostering-life-science-innovation-part-4-it-takes-a-village-federal-state-local-other-support)
Fostering Life Science Innovation: Part 4: It Takes a Village? (Federal, State, Local & Other Support)
[](https://blog.victech.com/inside-the-otc-at-university-of-kentucky-with-holly-clark-senior-commercialization-manager)
##### [Interview](https://blog.victech.com/inside-the-otc-at-university-of-kentucky-with-holly-clark-senior-commercialization-manager)
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
[](https://blog.victech.com/restara-medical-launches-to-transform-pressure-injury-prevention-through-outcome-verified-tissue-offloading)
##### [NEWS](https://blog.victech.com/restara-medical-launches-to-transform-pressure-injury-prevention-through-outcome-verified-tissue-offloading)
Restara Medical Launches to Transform Pressure Injury Prevention Through Outcome-Verified Tissue Offloading
[](https://blog.victech.com/fostering-life-science-innovation-part-1-an-ecosystem-roadmap)
##### [White Paper](https://blog.victech.com/fostering-life-science-innovation-part-1-an-ecosystem-roadmap)
Fostering Life Science Innovation: Part 1 – An Ecosystem Roadmap
[](https://blog.victech.com/sfc-fluidics-collaborating-with-duracell-to-power-innovative-diabetes-devices)
##### [News](https://blog.victech.com/sfc-fluidics-collaborating-with-duracell-to-power-innovative-diabetes-devices)
SFC Fluidics Collaborating with Duracell to Power Innovative Diabetes Devices
[](https://blog.victech.com/vic-fellows-spotlight-shreya-patel-md-mph)
##### [Interview](https://blog.victech.com/vic-fellows-spotlight-shreya-patel-md-mph)
VIC Fellows Spotlight: Shreya Patel, MD, MPH
[](https://blog.victech.com/from-the-corner-office-with-enhance-diagnostics)
##### [From The Corner Office](https://blog.victech.com/from-the-corner-office-with-enhance-diagnostics)
From the Corner Office with Enhance Diagnostics
[](https://victech.com)
**Technology Solutions For A Better World**
Our mission is to form and grow life science and emerging technology companies that shape the future by bringing innovative discoveries from research labs to commercial deployment.
[Subscribe](https://victech.com/newsletter/) to the VIC newsletter.
[Privacy Policy](https://www.iubenda.com/privacy-policy/89153966)
- [Innovators](https://victech.com/innovators/)
- [Inventors](https://victech.com/inventors/)
- [Foundry](https://victech.com/foundry/)
- [Fellows](https://victech.com/fellows/)
- [Investors](https://victech.com/investors-2/)
- [About](https://victech.com/about/)
- [Our Team](https://victech.com/team/)
- [Business Model](https://victech.com/business-model/)
- [Portfolio Companies](https://victech.com/portfolio-companies/)
- [Careers](https://victech.com/careers/)
- [News](https://blog.victech.com/)
- [Contact](https://victech.com/contact/)